Sunflower Pharmaceutical: Senior executive Ma Xin resigns

Sunflower Pharmaceutical Group (SZSE:002737) announced that Deputy General Manager Ma Xin has resigned from his position due to retirement, effective immediately. According to the company's statement, Ma Xin will no longer hold any position within the company or its subsidiaries. The announcement confirms that Ma Xin does not directly hold any shares in the company, and his investment share in the 2022 employee stock ownership plan has been handled according to relevant regulations. The board of directors expressed their gratitude for Ma Xin's contributions during his tenure. The resignation is in accordance with relevant laws, regulations, and the company's articles of association.